OceanFirst Financial Corp. (OCFC) Holding Trimmed by Wedge Capital Management LLP NC

Quantum Capital Management LLC NJ acquired a new position in OceanFirst Financial Corp. during the third quarter worth approximately $201,000. AQR Capital Management LLC acquired a new position in OceanFirst Financial Corp. during the fourth quarter worth approximately $205,000.

Wedge Capital Management L L P NC decreased its position in OceanFirst Financial Corp. (NASDAQ:OCFC) by 3.3% during the first quarter, Holdings Channel reports. The institutional investor owned 504,358 shares of the savings and loans company’s stock after selling 17,052 shares during the period. Wedge Capital Management L L P NC’s holdings in OceanFirst Financial Corp. were worth $14,210,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the company. Quantum Capital Management LLC NJ acquired a new position in OceanFirst Financial Corp. during the third quarter worth approximately $201,000. AQR Capital Management LLC acquired a new position in OceanFirst Financial Corp. during the fourth quarter worth approximately $205,000. First Republic Investment Management Inc. acquired a new position in OceanFirst Financial Corp. during the fourth quarter worth approximately $300,000. Emerald Advisers Inc. PA acquired a new position in OceanFirst Financial Corp. during the third quarter worth approximately $337,000. Finally, Highbridge Capital Management LLC acquired a new position in OceanFirst Financial Corp. during the fourth quarter worth approximately $394,000. 55.62% of the stock is currently owned by institutional investors and hedge funds.

OceanFirst Financial Corp. (NASDAQ:OCFC) traded down 0.46% during trading on Friday, reaching $28.10. 83,367 shares of the company’s stock traded hands. The stock has a market cap of $896.39 million, a price-to-earnings ratio of 25.20 and a beta of 0.59. The company’s 50 day moving average is $27.79 and its 200-day moving average is $26.91. OceanFirst Financial Corp. has a 52-week low of $16.77 and a 52-week high of $30.70.

The business also recently declared a quarterly dividend, which will be paid on Friday, May 19th. Stockholders of record on Monday, May 8th will be given a dividend of $0.15 per share. The ex-dividend date of this dividend is Thursday, May 4th. This is a boost from OceanFirst Financial Corp.’s previous quarterly dividend of $0.13. This represents a $0.60 annualized dividend and a dividend yield of 2.14%. OceanFirst Financial Corp.’s dividend payout ratio is currently 61.22%.

OCFC has been the topic of a number of recent research reports. Keefe, Bruyette & Woods reaffirmed a “buy” rating and set a $32.00 price target on shares of OceanFirst Financial Corp. in a research report on Wednesday. Zacks Investment Research lowered shares of OceanFirst Financial Corp. from a “strong-buy” rating to a “hold” rating in a report on Friday. Finally, Sandler O’Neill lowered shares of OceanFirst Financial Corp. from a “buy” rating to a “hold” rating in a report on Monday, January 30th.

In other news, Director Michael D. Devlin sold 4,801 shares of the company’s stock in a transaction dated Tuesday, February 14th. The stock was sold at an average price of $29.72, for a total transaction of $142,685.72. Following the sale, the director now directly owns 129,614 shares in the company, valued at $3,852,128.08. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director John R. Garbarino sold 3,000 shares of the company’s stock in a transaction dated Monday, February 13th. The shares were sold at an average price of $29.00, for a total value of $87,000.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 144,642 shares of company stock worth $4,222,224. Company insiders own 11.10% of the company’s stock.

OceanFirst Financial Corp. Company Profile

OceanFirst Financial Corp. is a holding company for OceanFirst Bank (the Bank). The Company is a savings and loan holding company. The Bank’s principal business is attracting retail and business deposits in the communities surrounding its branch offices and investing those deposits primarily in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate and other commercial loans.

Want to see what other hedge funds are holding OCFC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OceanFirst Financial Corp. (NASDAQ:OCFC).

Related Posts:

  • No Related Posts

Alliancebernstein LP Sells 292938 Shares of Altria Group Inc (MO)

Quantum Capital Management LLC NJ acquired a new stake in shares of Altria Group in the third quarter valued at $114,000. Northwest Investment Counselors LLC raised its stake in shares of Altria Group by 557.0% in the third quarter. Northwest Investment Counselors LLC now owns 1,820 shares of …

Altria Group logoAlliancebernstein L.P. trimmed its stake in Altria Group Inc (NYSE:MO) by 2.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,522,139 shares of the company’s stock after selling 292,938 shares during the period. Alliancebernstein L.P. owned 0.55% of Altria Group worth $751,386,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in MO. NewSquare Capital LLC grew its position in Altria Group by 4,734.7% in the third quarter. NewSquare Capital LLC now owns 108,780 shares of the company’s stock worth $109,000 after acquiring an additional 106,530 shares during the period. Balentine LLC raised its stake in shares of Altria Group by 32.4% in the second quarter. Balentine LLC now owns 1,460 shares of the company’s stock valued at $109,000 after acquiring an additional 357 shares in the last quarter. Quantum Capital Management LLC NJ acquired a new stake in shares of Altria Group in the third quarter valued at $114,000. Northwest Investment Counselors LLC raised its stake in shares of Altria Group by 557.0% in the third quarter. Northwest Investment Counselors LLC now owns 1,820 shares of the company’s stock valued at $115,000 after acquiring an additional 1,543 shares in the last quarter. Finally, Oak Point Wealth Management acquired a new stake in Altria Group in the fourth quarter valued at $120,000. Hedge funds and other institutional investors own 62.54% of the company’s stock.

How to Become a New Pot Stock Millionaire

In related news, CEO Brian W. Quigley sold 3,464 shares of the company’s stock in a transaction that occurred on Friday, March 2nd. The shares were sold at an average price of $62.40, for a total value of $216,153.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP W Hildebrandt Surgner, Jr. sold 3,200 shares of the company’s stock in a transaction that occurred on Friday, March 2nd. The shares were sold at an average price of $62.34, for a total transaction of $199,488.00. The disclosure for this sale can be found here. Insiders sold 28,117 shares of company stock valued at $1,821,707 over the last quarter. Insiders own 0.11% of the company’s stock.

MO opened at $57.78 on Friday. Altria Group Inc has a fifty-two week low of $56.08 and a fifty-two week high of $77.79. The stock has a market cap of $121,590.73, a P/E ratio of 17.09, a price-to-earnings-growth ratio of 1.86 and a beta of 0.62. The company has a current ratio of 0.64, a quick ratio of 0.31 and a debt-to-equity ratio of 0.85.

Altria Group (NYSE:MO) last announced its quarterly earnings results on Thursday, February 1st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.80 by $0.11. The company had revenue of $4.71 billion for the quarter, compared to analyst estimates of $4.80 billion. Altria Group had a net margin of 39.97% and a return on equity of 50.01%. Altria Group’s revenue was down .4% compared to the same quarter last year. During the same quarter last year, the business earned $0.68 earnings per share. sell-side analysts predict that Altria Group Inc will post 4.01 earnings per share for the current fiscal year.

Altria Group announced that its Board of Directors has approved a stock buyback plan on Thursday, February 1st that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the company to reacquire shares of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s board believes its shares are undervalued.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 10th. Stockholders of record on Thursday, March 15th were issued a $0.70 dividend. The ex-dividend date was Wednesday, March 14th. This is a boost from Altria Group’s previous quarterly dividend of $0.66. This represents a $2.80 annualized dividend and a dividend yield of 4.85%. Altria Group’s dividend payout ratio (DPR) is 82.84%.

A number of equities analysts recently issued reports on MO shares. Zacks Investment Research raised Altria Group from a “hold” rating to a “buy” rating and set a $72.00 price target on the stock in a report on Monday, April 9th. Citigroup lowered Altria Group from a “buy” rating to a “neutral” rating and set a $75.00 price objective on the stock. in a report on Wednesday. Morgan Stanley decreased their price target on Altria Group from $74.00 to $70.00 and set an “equal weight” rating on the stock in a research note on Wednesday. Vetr upgraded Altria Group from a “buy” rating to a “strong-buy” rating and set a $76.87 price objective for the company in a research report on Monday, February 12th. Finally, Wells Fargo boosted their price target on Altria Group from $80.00 to $85.00 and gave the company an “outperform” rating in a report on Thursday, January 4th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $74.21.

ILLEGAL ACTIVITY WARNING: This piece of content was published by Week Herald and is the sole property of of Week Herald. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The legal version of this piece of content can be viewed at https://weekherald.com/2018/04/20/altria-group-inc-mo-holdings-reduced-by-alliancebernstein-l-p.html.

About Altria Group

Altria Group, Inc is a holding company. The Company’s segments include smokeable products, smokeless products and wine. The Company’s subsidiaries include Philip Morris USA Inc (PM USA), which is engaged in the manufacture and sale of cigarettes in the United States; John Middleton Co (Middleton), which is engaged in the manufacture and sale of machine-made cigars and pipe tobacco, and UST LLC (UST), which, through its subsidiaries, including U.S.

Institutional Ownership by Quarter for Altria Group (NYSE:MO)

Receive News & Ratings for Altria Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Altria Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Brown Advisory Securities LLC Increases Position in Altria Group Inc (NYSE:MO)

Quantum Capital Management LLC NJ purchased a new position in Altria Group during the third quarter valued at approximately $114,000. Northwest Investment Counselors LLC lifted its holdings in Altria Group by 557.0% during the third quarter. Northwest Investment Counselors LLC now owns 1,820 …

Altria Group logoBrown Advisory Securities LLC lifted its stake in Altria Group Inc (NYSE:MO) by 5.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 28,490 shares of the company’s stock after acquiring an additional 1,483 shares during the quarter. Brown Advisory Securities LLC’s holdings in Altria Group were worth $2,032,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. NewSquare Capital LLC boosted its holdings in shares of Altria Group by 4,734.7% in the third quarter. NewSquare Capital LLC now owns 108,780 shares of the company’s stock worth $109,000 after buying an additional 106,530 shares during the last quarter. Balentine LLC lifted its holdings in Altria Group by 32.4% during the second quarter. Balentine LLC now owns 1,460 shares of the company’s stock valued at $109,000 after purchasing an additional 357 shares in the last quarter. Quantum Capital Management LLC NJ purchased a new position in Altria Group during the third quarter valued at approximately $114,000. Northwest Investment Counselors LLC lifted its holdings in Altria Group by 557.0% during the third quarter. Northwest Investment Counselors LLC now owns 1,820 shares of the company’s stock valued at $115,000 after purchasing an additional 1,543 shares in the last quarter. Finally, Oak Point Wealth Management purchased a new position in Altria Group during the fourth quarter valued at approximately $120,000. 62.54% of the stock is currently owned by institutional investors.

How to Become a New Pot Stock Millionaire

In related news, CEO Craig A. Johnson sold 14,953 shares of the business’s stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $66.59, for a total value of $995,720.27. Following the sale, the chief executive officer now owns 64,809 shares in the company, valued at $4,315,631.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Brian W. Quigley sold 3,464 shares of the business’s stock in a transaction on Friday, March 2nd. The stock was sold at an average price of $62.40, for a total transaction of $216,153.60. The disclosure for this sale can be found here. Insiders sold 28,117 shares of company stock worth $1,821,707 in the last 90 days. 0.11% of the stock is currently owned by company insiders.

MO has been the topic of several analyst reports. Vetr raised shares of Altria Group from a “sell” rating to a “hold” rating and set a $69.29 price target on the stock in a report on Thursday, December 28th. Zacks Investment Research downgraded shares of Altria Group from a “hold” rating to a “sell” rating in a report on Tuesday, January 2nd. Wells Fargo lifted their price target on shares of Altria Group from $80.00 to $85.00 and gave the company an “outperform” rating in a report on Thursday, January 4th. Jefferies Group raised shares of Altria Group from a “hold” rating to a “buy” rating and lowered their price target for the company from $70.04 to $70.00 in a report on Friday, January 19th. Finally, Piper Jaffray lifted their price target on shares of Altria Group from $76.00 to $81.00 and gave the company an “overweight” rating in a report on Friday, February 2nd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $74.21.

Shares of Altria Group stock traded down $3.72 on Thursday, hitting $57.78. 24,260,522 shares of the company traded hands, compared to its average volume of 7,991,316. The stock has a market cap of $121,590.73, a P/E ratio of 17.09, a PEG ratio of 1.86 and a beta of 0.62. The company has a debt-to-equity ratio of 0.85, a current ratio of 0.64 and a quick ratio of 0.31. Altria Group Inc has a 52 week low of $56.08 and a 52 week high of $77.79.

Altria Group (NYSE:MO) last released its quarterly earnings data on Thursday, February 1st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.11. The firm had revenue of $4.71 billion for the quarter, compared to analysts’ expectations of $4.80 billion. Altria Group had a net margin of 39.97% and a return on equity of 50.01%. The company’s revenue for the quarter was down .4% compared to the same quarter last year. During the same quarter last year, the business posted $0.68 earnings per share. equities analysts expect that Altria Group Inc will post 4.01 EPS for the current year.

Altria Group announced that its Board of Directors has authorized a stock repurchase program on Thursday, February 1st that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the company to reacquire shares of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s board believes its stock is undervalued.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, April 10th. Investors of record on Thursday, March 15th were given a $0.70 dividend. This represents a $2.80 annualized dividend and a yield of 4.85%. The ex-dividend date of this dividend was Wednesday, March 14th. This is a boost from Altria Group’s previous quarterly dividend of $0.66. Altria Group’s payout ratio is currently 82.84%.

WARNING: This story was first reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are reading this story on another domain, it was stolen and reposted in violation of United States & international copyright law. The original version of this story can be accessed at https://www.thelincolnianonline.com/2018/04/19/brown-advisory-securities-llc-acquires-1483-shares-of-altria-group-inc-mo.html.

About Altria Group

Altria Group, Inc is a holding company. The Company’s segments include smokeable products, smokeless products and wine. The Company’s subsidiaries include Philip Morris USA Inc (PM USA), which is engaged in the manufacture and sale of cigarettes in the United States; John Middleton Co (Middleton), which is engaged in the manufacture and sale of machine-made cigars and pipe tobacco, and UST LLC (UST), which, through its subsidiaries, including U.S.

Institutional Ownership by Quarter for Altria Group (NYSE:MO)

Receive News & Ratings for Altria Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Altria Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

West Pharmaceutical Services (NYSE:WST) Shares Sold by Two Sigma Investments LP

West Pharmaceutical Services logo Two Sigma Investments LP decreased its position in West Pharmaceutical Services (NYSE:WST) by 27.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 33,186 shares of …

West Pharmaceutical Services logoTwo Sigma Investments LP decreased its position in West Pharmaceutical Services (NYSE:WST) by 27.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 33,186 shares of the medical instruments supplier’s stock after selling 12,610 shares during the quarter. Two Sigma Investments LP’s holdings in West Pharmaceutical Services were worth $3,274,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Stone Ridge Asset Management LLC purchased a new stake in West Pharmaceutical Services in the fourth quarter valued at approximately $917,000. Deutsche Bank AG increased its position in shares of West Pharmaceutical Services by 4.7% during the fourth quarter. Deutsche Bank AG now owns 209,854 shares of the medical instruments supplier’s stock worth $20,702,000 after acquiring an additional 9,437 shares during the period. Jefferies Group LLC purchased a new stake in shares of West Pharmaceutical Services during the fourth quarter worth $1,285,000. Dorsey Wright & Associates increased its position in shares of West Pharmaceutical Services by 3.5% during the fourth quarter. Dorsey Wright & Associates now owns 29,329 shares of the medical instruments supplier’s stock worth $2,894,000 after acquiring an additional 984 shares during the period. Finally, Advisor Group Inc. increased its position in shares of West Pharmaceutical Services by 12.3% during the fourth quarter. Advisor Group Inc. now owns 8,959 shares of the medical instruments supplier’s stock worth $884,000 after acquiring an additional 981 shares during the period. 94.39% of the stock is currently owned by institutional investors.

How to Become a New Pot Stock Millionaire

Shares of WST stock traded down $0.20 on Thursday, reaching $91.76. 325,141 shares of the stock were exchanged, compared to its average volume of 405,712. The company has a current ratio of 2.66, a quick ratio of 1.89 and a debt-to-equity ratio of 0.15. The company has a market cap of $6,744.61, a P/E ratio of 37.67, a PEG ratio of 2.80 and a beta of 1.11. West Pharmaceutical Services has a twelve month low of $80.02 and a twelve month high of $103.36.

West Pharmaceutical Services (NYSE:WST) last issued its earnings results on Thursday, February 15th. The medical instruments supplier reported $0.64 EPS for the quarter, topping analysts’ consensus estimates of $0.62 by $0.02. The firm had revenue of $415.60 million during the quarter, compared to the consensus estimate of $416.90 million. West Pharmaceutical Services had a net margin of 9.42% and a return on equity of 14.68%. The company’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.54 earnings per share. equities analysts forecast that West Pharmaceutical Services will post 2.84 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 2nd. Investors of record on Wednesday, April 18th will be paid a dividend of $0.14 per share. The ex-dividend date is Tuesday, April 17th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.61%. West Pharmaceutical Services’s payout ratio is currently 20.14%.

West Pharmaceutical Services declared that its Board of Directors has approved a share repurchase program on Thursday, February 15th that permits the company to buyback 800,000 shares. This buyback authorization permits the medical instruments supplier to buy shares of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s management believes its stock is undervalued.

A number of research firms have recently weighed in on WST. Zacks Investment Research raised West Pharmaceutical Services from a “sell” rating to a “hold” rating in a research report on Friday, January 26th. Goldman Sachs began coverage on West Pharmaceutical Services in a research report on Wednesday, January 24th. They set a “neutral” rating and a $110.00 price objective on the stock. Finally, ValuEngine lowered West Pharmaceutical Services from a “hold” rating to a “sell” rating in a research report on Saturday, April 7th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $108.17.

ILLEGAL ACTIVITY NOTICE: This piece was first posted by Week Herald and is the property of of Week Herald. If you are accessing this piece on another website, it was illegally stolen and republished in violation of international trademark & copyright laws. The legal version of this piece can be viewed at https://weekherald.com/2018/04/19/two-sigma-investments-lp-has-3-27-million-holdings-in-west-pharmaceutical-services-inc-wst.html.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for West Pharmaceutical Services and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Intel (INTC) Holdings Boosted by Webster Bank NA

Also, CEO Brian M. Krzanich sold 5,873 shares of the business’s stock in a transaction on Wednesday, January 24th. The stock was sold at an average price of $45.58, for a total value of $267,691.34. Following the completion of the transaction, the chief executive officer now directly owns 259,082 …

Intel logoWebster Bank N. A. increased its position in shares of Intel (NASDAQ:INTC) by 45.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 80,673 shares of the chip maker’s stock after acquiring an additional 25,252 shares during the period. Webster Bank N. A.’s holdings in Intel were worth $3,724,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Oaktop Capital Management II L.P. purchased a new position in Intel in the 2nd quarter worth about $1,114,000. Swiss National Bank increased its stake in Intel by 2.9% in the 2nd quarter. Swiss National Bank now owns 17,274,702 shares of the chip maker’s stock worth $582,848,000 after purchasing an additional 483,200 shares in the last quarter. Whalerock Point Partners LLC increased its stake in Intel by 32.8% in the 4th quarter. Whalerock Point Partners LLC now owns 37,490 shares of the chip maker’s stock worth $1,730,000 after purchasing an additional 9,250 shares in the last quarter. Berkshire Asset Management LLC PA increased its stake in Intel by 9.0% in the 4th quarter. Berkshire Asset Management LLC PA now owns 443,604 shares of the chip maker’s stock worth $20,477,000 after purchasing an additional 36,802 shares in the last quarter. Finally, OMERS ADMINISTRATION Corp purchased a new position in Intel in the 2nd quarter worth about $1,407,000. 69.02% of the stock is currently owned by hedge funds and other institutional investors.

How to Become a New Pot Stock Millionaire

NASDAQ:INTC traded down $1.39 during trading hours on Thursday, reaching $52.22. The company had a trading volume of 25,419,541 shares, compared to its average volume of 34,806,453. Intel has a one year low of $33.23 and a one year high of $54.35. The stock has a market capitalization of $250,477.09, a price-to-earnings ratio of 15.09, a price-to-earnings-growth ratio of 1.80 and a beta of 0.95. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.69 and a quick ratio of 1.29.

Intel (NASDAQ:INTC) last announced its quarterly earnings results on Thursday, January 25th. The chip maker reported $1.08 earnings per share for the quarter, beating analysts’ consensus estimates of $0.86 by $0.22. Intel had a return on equity of 24.33% and a net margin of 15.30%. The firm had revenue of $17.05 billion for the quarter, compared to analysts’ expectations of $16.34 billion. During the same period in the prior year, the business posted $0.79 earnings per share. The business’s revenue was up 4.1% compared to the same quarter last year. research analysts expect that Intel will post 3.54 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, June 1st. Shareholders of record on Monday, May 7th will be given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 2.30%. The ex-dividend date of this dividend is Friday, May 4th. Intel’s dividend payout ratio (DPR) is 34.68%.

A number of brokerages recently weighed in on INTC. Barclays lifted their price target on Intel from $55.00 to $60.00 and gave the stock an “overweight” rating in a research note on Thursday. Bank of America reissued a “buy” rating and issued a $65.00 price target on shares of Intel in a research note on Wednesday. Vetr cut Intel from a “buy” rating to a “hold” rating and set a $54.70 price target on the stock. in a research note on Wednesday. Macquarie reissued a “buy” rating and issued a $58.00 price target on shares of Intel in a research note on Thursday, April 12th. Finally, Tigress Financial raised Intel from a “neutral” rating to a “buy” rating and set a $50.34 target price on the stock in a research note on Thursday, April 5th. Three investment analysts have rated the stock with a sell rating, fifteen have assigned a hold rating, twenty-six have given a buy rating and two have assigned a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $51.10.

In other Intel news, VP Kevin Thomas Mcbride sold 686 shares of the business’s stock in a transaction on Wednesday, February 21st. The stock was sold at an average price of $46.56, for a total value of $31,940.16. Following the transaction, the vice president now owns 6,472 shares of the company’s stock, valued at $301,336.32. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Brian M. Krzanich sold 5,873 shares of the business’s stock in a transaction on Wednesday, January 24th. The stock was sold at an average price of $45.58, for a total value of $267,691.34. Following the completion of the transaction, the chief executive officer now directly owns 259,082 shares in the company, valued at approximately $11,808,957.56. The disclosure for this sale can be found here. Insiders sold 123,914 shares of company stock worth $6,011,490 over the last quarter. Company insiders own 0.03% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece was reported by Week Herald and is the sole property of of Week Herald. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at https://weekherald.com/2018/04/19/intel-co-intc-stake-raised-by-webster-bank-n-a.html.

About Intel

Intel Corporation designs, manufactures, and sells computer, networking, data storage, and communication platforms worldwide. The company operates through Client Computing Group, Data Center Group, Internet of Things Group, Non-Volatile Memory Solutions Group, Programmable Solutions Group, and All Other segments.

Institutional Ownership by Quarter for Intel (NASDAQ:INTC)

Receive News & Ratings for Intel Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Intel and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts